Market Data/Companies/Healx

Healx

GRCHealthcare

Healx is a rare disease biotechnology company that uses generative AI for drug discovery.

2014
Founded
12y
Age
$115M
Total funding
Healthcare
Area

Funding timeline

Aug 2024
Series C - Healx
$47M
Apr 2024
Grant - Healx
Undisclosed
Oct 2019
Series B - Healx
$56M
Jun 2019
Series B - Healx
Undisclosed
Jul 2018
Series A - Healx
$10M
Oct 2016
Seed Round - Healx
$2M
Mar 2016
Non Equity Assistance - Healx
Undisclosed
← Back to Market Data